Basel Switzerland, Kuopio Finland – December 15th, 2020.
Haritha Samaranayake, MD, PhD, Medical Director of Aurealis Therapeutics will give a talk about development of AUP16, the company´s lead product for non-healing wounds such as diabetic foot ulcer. The presentation is titled “Development of a Live Biotherapeutic to treat diabetic foot ulcer“ and is scheduled for Tuesday, December 15th, 2020 at 14:30 CET.
More information about the event can be found here:
For more information about Aurealis Therapeutics and AUP16, please contact:
Juha Yrjänheikki, CEO Email: juha(at)aurealistherapeutics.com